latest shaws research - $1.15

Shaws research 22/3/10 values RES at $4.04 DCF with a 75% risk discount to a 12 month target of $1.15. Previous target of 80c has been increased due to progress of the project.

Rated a buy with a speculative nature with the likelyhood of share price appreiation assuming completion of key milestones.

Research report is in PDF format so I cant copy and paste so will talk to the source about getting in a format that can be shared.